# Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

> **NCT03461081** · PHASE1 · COMPLETED · sponsor: **Jeil Pharmaceutical Co., Ltd.** · enrollment: 32 (actual)

## Conditions studied

- Hypertension With Hyperlipidemia

## Interventions

- **DRUG:** telmisartan/amlodipine and atorvastatin

## Key facts

- **NCT ID:** NCT03461081
- **Lead sponsor:** Jeil Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-07
- **Primary completion:** 2017-07-12
- **Final completion:** 2017-12-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03461081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03461081, "Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03461081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*